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Background: Sixty percent of eating disorders do not meet criteria for anorexia- or bulimia nervosa, as defined by
the Diagnostic and Statistical Manual version 4 (DSM-IV). Instead they are diagnosed as ‘eating disorders not
otherwise specified’ (EDNOS). Discrepancies between criteria and clinical reality currently hampering eating disorder
diagnoses in the DSM-IV will be addressed by the forthcoming DSM-V. However, future diagnoses for eating
disorders will rely on current advances in the fields of neuroimaging and genetics for classification of symptoms
that will ultimately improve treatment.
Discussion: Here we debate the classification issues, and discuss how brain imaging and genetic discoveries might
be interwoven into a model of eating disorders to provide better classification and treatment. The debate concerns:
a) current issues in the classification of eating disorders in the DSM-IV, b) changes proposed for DSM-V, c)
neuroimaging eating disorder research and d) genetic eating disorder research.
Summary: We outline a novel evidence-based ‘impulse control’ spectrum model of eating disorders. A model of
eating disorders is proposed that will aid future diagnosis of symptoms, coinciding with contemporary suggestions
by clinicians and the proposed changes due to be published in the DSM-V.
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Despite obvious physical and behavioral signs, up to sixty
percent of referrals for eating disorders (ED), are not
given a specific diagnosis, but instead labeled with Eating
Disorder Not Otherwise Specified (EDNOS) [1-3]. Anor-
exia Nervosa (AN) and Bulimia Nervosa (BN) are the
specific ED diagnoses available in the Diagnostic and
Statistical Manual of Mental Disorders version 4 (DSM-
IV), currently being revised for a fifth edition due to be
released in May 2013 [4]. AN and BN are recognizable
by severe emaciation and uncontrolled eating patterns
respectively, but these indicators are not enough for diag-
nosis following the current criteria. Additionally, despite
the presence of neuropsychological disturbances in
people with ED being known (e.g. ruminations and
obsessions about weight, shape and eating), they are* Correspondence: samantha.brooks@neuro.uu.se
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reproduction in any medium, provided the ormerely eluded to in the current diagnostic criteria (e.g.
fear of weight gain and a sense of lacking control). The
diagnostic machinery and treatment responses that rely
heavily on the DSM-IV ED criteria to assess improve-
ment in symptoms will be re-oiled in 2013 following the
publication of the DSM-V, which plans to loosen the
boundaries in line with a more transdiagnostic approach.
This paradigm shift has been undoubtedly buoyed by the
continuing advances in our understanding of the under-
lying neurobiological mechanisms of disordered eating,
through genetic studies, and illustrated using technolo-
gies that measure brain structure and function. In this
debate article, we will briefly summarize the current
DSM-IV criteria underlying the ED diagnoses; we will
then encapsulate findings from brain imaging and genetic
studies in people with ED, against the background of the
old and new diagnostic systems. We finish by proposing
an “impulse control” spectrum model of eating behavior
that may help to better visualize symptom thresholdsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Eating disorders (ED) which, by definition in the DSM-
IV constitute anorexia nervosa (AN) and bulimia nervosa
(BN) are typically female adolescent-onset psychiatric
conditions. A third type, binge eating disorder (BED) is
informally mentioned in the Appendix of DSM-IV, but is
set to be included as a third ED in the forthcoming
DSM-V. Current lifetime prevalence rates using screen-
ing and diagnostic measures of AN and BN for females
in Western populations are estimated to be approxi-
mately 0.3 and 0.9 percent respectively [5], for males the
prevalence rate has been reported as 0.03 percent, but
data is only available for AN [6]. Estimates based on epi-
demiological measures are slightly higher for females, at
0.7 percent for AN and 2 percent for BN females.
Current DSM-IV diagnostic criteria for EDs are narrowly
defined, specific to female adults and subject to altera-
tions that will be set out in the imminently published
DSM-V. Diagnosing a specific ED is further complicated
by other major psychiatric conditions that share similar
clinical symptoms, such as anxiety and depression [7].
Sufferers of AN are most identifiable by their severe
emaciation, cognitive disturbances and continued refusal
to eat. Presently, a formal diagnosis of AN must satisfy
three DSM-IV criteria: refusal to maintain body weight
at or above the expected minimum, thus weighing 85
percent or less of expected body weight or a Body Mass
Index (BMI, kg/m2) of ≤17.5; possessing an intense,
pathological fear of gaining weight; and amenorrhea
(lack of menses) for three consecutive months not
related to any other medical condition. Recommenda-
tions for amendments to the DSM-V include that the
word refusal be removed as a potentially pejorative term
that is difficult to ascertain clinically [8]. Furthermore, it
is difficult to measure intense fear, particularly in those
who deny fear, and so it is suggested that an extra clause
be added to address this [8,9]. Finally, it is proposed that
amenorrhea be deleted from the formal diagnostic cri-
teria in DSM-V to account for pre-pubescent female suf-
ferers, and the small percentage of males who reportedly
suffer [10]. Within the main diagnosis of AN, two sub-
types are recognized by the DSM-IV that differ in the
amount of food consumed: restricting and binge purging
AN. The former is the most severe, whereby sufferers
consume only morsels of food often with fatal conse-
quences if left untreated, whereas in the latter sufferers
eat relatively more yet are still emaciated due to the
adoption of compensatory measures to reduce weight (e.
g. vomiting and laxative abuse). However, due to much
‘cross-over’ between the subtypes in the ‘current episode’
of illness it has been suggested that for DSM-V, in line
with the timeframe used for the diagnosis of BN, that
the subtype behavior (e.g. restricting versus bingeing) beconsistently present for the last three months [11]. In
both subtypes, sufferers exhibit severe cognitive distur-
bances. These include; excessive perfectionism, asceti-
cism [12], cognitive rigidity and deficits in set-shifting
(concrete adherence to rigid rules rather than being able
to adjust to changing rules) which also pertains to exces-
sive attention to detail [13], and ruminations, obsessions
about food and excessive concerns about weight and
shape [14]. These cognitive deficits are often present
during adolescence before the onset of eating disorder,
and can remain following weight restoration in recovery,
and are regarded by some as potential indicators of risk
for developing an ED [15].
To be diagnosed with BN, the DSM-IV criteria are: re-
current episodes of bingeing and purging must occur at
least twice weekly over a period of three months. A binge
constitutes the consumption of an amount of food that
most people would consider to be large, whilst lacking
control over eating over a short period of time (e.g. half
an hour). Purging includes compensatory behaviors such
as vomiting, laxative abuse, excessive exercise or inter-
mittent food restriction to counteract weight gain. How-
ever, a recent review showed that bulimic symptoms
were still largely present in individuals reporting a lower
frequency (e.g. once per week) of binges and purges [16],
and so it is likely that for the DSM-V the frequency will
be lowered to once per week over a three month period.
Currently, the DSM-IV recognizes two subtypes of BN:
purging and non-purging, the former requires that com-
pensatory measures occur intermittently between binge
episodes, whereas the latter does not require purging to
occur, but instead bouts of restricted eating (which dif-
fers from AN due to the lack of emaciation in BN). How-
ever, according to one recent review, it is currently
unclear how to precisely define non-purging behavior
[17], and thus, it is suggested that the subtypes be deleted
from the BN definition for DSM-V.
BED is not currently recognized as a formal diagnosis
of ED by the DSM-IV but is instead included in the Ap-
pendix. However, a list of reasons are highlighted based
on a recent review [18] that support the suggestion for
BED to be formally recognized as a third type of ED in
the DSM-V. One of the main reasons is that the dys-
functional eating behaviors underlying BED have been
compared to both AN and BN (e.g. fear of weight gain,
lack of control over eating). In terms of ED antecedents
there is evidence that BED has a strong familial history
component and is not simply a form of obesity (which is
not currently recognized as an ED in the DSM-IV, nor
suggested as an ED in DSM-V). Furthermore, BED has a
distinct demographic profile in that it is predominantly
found in males with a later age of onset to other EDs. It
is also plausible that BED can be included as an ED from
the range of psychological disturbances observed in
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who are obese). For example, excessive concerns about
weight and shape, personality disturbance and psychi-
atric comorbidities in the form of mood and anxiety dis-
orders, combined with a lower quality of life. However,
the difficulties in recognizing BED as a formal ED in-
clude; a lack of diagnostic stability and high levels of re-
mission. Additionally, BED coincides with medical
morbidities that are not observed in other EDs, for ex-
ample the incidence of metabolic syndrome (e.g. hyper-
tension, type 2 diabetes). However, it has been shown
that highly specific treatments are effective for BED [18],
supporting the clinical relevance of recognizing it as a
third ED. Thus, it is proposed, in line with the criteria
for BN, that BED be defined by recurrent episodes of
binge eating (e.g. at least one per week for three
months), combined with a sense of lack of control over
eating, and without inappropriate compensatory beha-
viors (e.g. purging, excessive exercise).
Those who exhibit pathological disordered eating
behaviors but who do not meet the full criteria for AN
or BN as stipulated in the DSM-IV described above, are
instead diagnosed as ‘Eating Disorder Not Otherwise Spe-
cified’ (EDNOS). According to recent reports the diagno-
sis of EDNOS, which is marked by cognitive dysfunction
and suboptimal functioning is given to up to sixty per-
cent of cases presenting to medical professionals [1-3].
This is problematic, since it has been shown that reduc-
tion of ‘psychological dysfunction’ is linked to lower re-
lapse rates than recovery that is defined by the absence
of DSM-IV criteria, e.g. weight and menses restoration
[19]. Thus, there are some major issues in the current
DSM-IV that prevent an effective diagnosis and subse-
quent treatment. These include males, pre-pubescent
girls, and adolescent females with regular menses who
are engaged in infrequent bingeing and purging, whose
body weight exceeds the 85th percentile expected for
their age but do not have healthy eating patterns (i.e. are
persistently worried about their weight, shape and eat-
ing), those who deny, or for whom it is difficult to meas-
ure a pathological fear of gaining weight. These
discrepancies are an obvious mismatch of the current
diagnostic system to clinical reality [3] in that patients
assigned to the EDNOS category are not adequately sup-
ported by treatments currently tailored to a definite
diagnosis of AN and BN as emphasized by the current
DSM-IV. These treatments include: a) Cognitive Behav-
ioral Therapy (CBT) that counters dysfunctional cogni-
tions, b) psychodynamic approaches that address
‘hysterical’ psychological conflicts and conversion disor-
ders, c) pharmacological interventions such as Selective
Serotonin Reuptake Inhibitors (SSRIs) or low-dose sec-
ond generation anti-psychotics that tackle neurotrans-
mitter imbalances in the brain. It has been suggestedthat the EDNOS category could be diminished to repre-
sent a mere eight percent of cases (instead of 60 percent)
with new diagnostic labels of ‘purging disorder’ [20] and
‘restrained eating disorder’ [3], which meet some but not
all of the extreme criteria for BN and AN respectively.
To introduce contemporary neurobiological know-
ledge of eating disorders in to the debate on how to best
improve classification of eating disorders, we will next
highlight conclusions from neuroimaging and genetic re-
search. By no means do we present an exhaustive meta-
analysis or review of the literature, but rather, set out
some recent findings and popular contemporary views
of the neurobiology of eating disorders. Finally, we
propose how these findings might be incorporated in to
an “impulse control” model of eating disorders, such
that we prompt a debate on what distinguishes separate
eating disorders, and whether it is plausible to include
them on a single spectrum.
Discussion
Brain imaging research in to disordered eating behaviour
This section summarizes conclusions drawn from re-
search involving functional brain imaging methods, that
provide some evidence to support a neural model of
eating disorders across a spectrum of restricted versus
impulsive eating behavior. It is not meant to be an ex-
haustive meta-analytical review, which has been done
by expert researchers in the field previously (see below)
but a summary of the main views arising from contem-
porary brain imaging findings, in an attempt to spark a
debate about a model of disordered eating behaviour.
As has been eloquently reviewed previously [21-24],
functional brain imaging studies of females with AN (in
comparison to healthy, age and gender matched con-
trols), particularly when viewing rewarding stimuli,
largely report aberrant, often reduced activation in
‘bottom-up’ mesolimbic regions associated with somatic
states (e.g. appetite) such as in the striatum, hippocam-
pus, amygdala, hypothalamus and cerebellum. This is
often in conjunction with increased activation in ‘top-
down’ prefrontal cortical (PFC) regions linked to cogni-
tive evaluation, attention and executive functioning (e.g.
working memory, goal-orientation, self-reference, evalu-
ation of salience) such as the dorsolateral prefrontal
cortex (DLPFC), medial prefrontal cortex (mPFC), orbi-
tofrontal cortex (OFC), and anterior cingulate cortex
(ACC). Furthermore, there appears to be a strong indi-
cation from various neuroimaging modalities (e.g. Posi-
tron Emission Tomography, Single Photon Emission
Tomography) that the subtypes of AN (e.g. restricting
and binge purging) can be distinguished by relatively
higher or lower activations to appetitive stimuli in these
regions [25]. Indeed other fMRI studies show that the
DLPFC, which appears to be highly activated when
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with AN [26,27], is strongly implicated in both appetite
suppression and working memory function [28-30].
Also, a recent neuropsychological study showed that
automatic appetite activation (using subliminal images
of food) interfered with a DLPFC-dependent working
memory task [31]. Thus, the excessive ruminations
about weight, shape and eating in those who pathologic-
ally restrain their appetite is reminiscent of classic, yet
excessive, working memory function. In turn, the ability
to restrain appetite in those with anorexia might be
associated with excessive top-down activation (mainly
DLPFC) to varying degrees (e.g. different levels of re-
straint between the subtypes of AN), combined with
varying levels of desire to restrain an over or underactive
appetitive system. Furthermore, recent evidence suggests
that the neural response during working memory per-
formance is modulated by genetic polymorphisms in
COMT and BDNF described below [32]. However, there
is one caveat to linking hyperactivation in the DLPFC to
excessive working memory function in AN: it is cur-
rently unclear whether increased DLPFC working
memory-related activation reflects a deficiency in work-
ing memory and a need to work harder.
Conversely, in those who exhibit binge eating behavior
(e.g. BN, BED), previous research summarises a neural
pattern to rewarding stimuli that is somewhat reversed,
with a reduced or sporadic response in PFC regions,
combined with hyperactivation in mesolimbic areas. In
further support, a recent fMRI study that directly com-
pared neural activation to food images in women with
AN and BN found a clear PFC vs. striatum response to
images of food [33]. However, it is also plausible that
binge eating might coincide with hypofunctioning of the
reward system [34], prompting the hypothesis that dur-
ing binge eating, like an addict, a person must consume
greater quantities of food to achieve the feeling of sati-
ation. Furthermore, there appears to be a differential
pattern of activation in binge eaters, when consuming
versus anticipating food consumption during fMRI (e.g.
[35]), suggesting that the model proposed here might be
more applicable to anticipation of food intake, and
cognitive biases towards food stimuli. It is also oftenFigure 1 Impulse-control spectrum model of eating disorders.observed that people who binge (e.g. those with BN)
have a strong desire to restrain their intake, and recent
evidence suggests that restraining one’s appetite
increases the chances of binge eating in those with a
genetic risk for binge eating [36]. Moreover, recent evi-
dence suggests that artificial stimulation of the DLPFC
using repetitive Transcranial Magnetic Stimuluation
(rTMS) reduces craving in those prone to binge-eat [37].
Thus, the neurobiological interactions underpinning
restrained and binge eating behaviour are complex. It is
proposed here that, in response to appetitive food stim-
uli that may underlie responses to food, a specific neural
signature, with sporadic dominance of restraint versus
binge eating can be mapped onto a single model with
the support of recent neuroimaging findings. See
Figure 1.
A commonality between all ED subtypes is seemingly
dysregulated neural activation in response to food stim-
uli in the parietal cortex, and the insular cortex in the
temporal lobe, regions associated with somatosensory
perception and interoceptive awareness [25,38]. One
might argue that somatosensory perception occurs via a
balance between basic bottom-up arousal systems, and
higher order top-down cognitive evaluations. Against
this background, it is proposed that an excessive activa-
tion at one or other extremes (e.g. restraint versus binge
eating systems) in those with eating disorders causes an
imbalanced convergence on these somatosensory brain
regions, associated with dysfunctional processing of the
body state (inexorably linked to body image distortions).
See Figure 2. Additionally, hyperactivation of the amyg-
dala is often seen across ED diagnoses [39,40] and likely
leads to anxiety experienced by most ED sufferers re-
gardless of subtype. Emotional experiences that derive
from somatosensory states can be positively or nega-
tively arousing (e.g. pleasant feelings during appetite sat-
isfaction versus unpleasant anxiety and anger) and are
linked to areas of the ‘temporoparietal junction’ that are
involved in creating a sense of self-control over one’s
actions [41]. It has long been established that people
with ED have problems identifying and expressing their
emotions [42], a core symptom known as alexithymia,
which has been further demonstrated in recent
Figure 2 Imbalanced PFC-mesolimbic convergence on the insular cortex in those with eating disorders.
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latory neural circuit between the PFC and mesolimbic
regions likely hampers a healthy orchestration of these
systems, leading to a ‘rate-limiting’ defect in the insula
[45] and other somatosensory regions that normally pro-
vide a solid sense of ‘emotional self ’ (See Figure 2).
Findings from fMRI research into obesity, which could
be regarded as representing the excessive appetitive ex-
treme of the proposed spectrum model of eating disor-
ders, fit well with the notions proposed here. One might
predict, against the background of the present taxonomy,
that people who are obese have deficits in prefrontal cor-
tical activation, particularly the DLPFC, combined with
hyperactivation of brain reward systems. Such a neural
substrate does appear to exist in obesity, in that a hyper-
sensitive reward system is demonstrated, in response to
various types of food stimuli [46], but particularly when
overweight people think about the taste of food [47].
Hyperactivation of reward systems when thinking of and/
or viewing food stimuli may well impinge on cognitive
systems, particularly memory and cognitive control, in
those who are obese [46]. However, causality is difficult
to determine, and it could also be that deficits in cogni-
tive processing prevent an adequate top-down control of
one’s impulsive responses, e.g. over-eating in those who
are obese. Thus, fMRI studies of obesity do seem to sup-
port the notion that specific eating disorder symptoms,
ranging from restraint to impulsivity, can be mapped on
to a single spectrum model, as proposed here.
Eating disorder cases that do not easily fit in to the
proposed model must also be considered in this debate.
For example, prima facie it is not easy to fit binge-purge
anorexia nervosa to the model, because such cases often
consume excessive amounts of food in one sitting, while
subsequently adopting compensatory measures (e.g.
vomiting, laxative abuse) to avoid weight gain, and so
might not easily fit the restrictive extreme. Furthermore,
profile analyses of individual diagnoses of eating disor-
ders often exhibit an inhibited and non-inhibited style
based on personality traits [48,49], suggesting that disor-
dered eating behaviour is based not on appetitive and
restricting temperaments, but more on personality
dimensions. However, we argue that the model can alsoexplain these cases, because we do not suggest that a
person is exclusively restrictive or impulsive. Rather, we
purport that, depending on one’s response to fluctuating
social/environmental challenges, at any given time a per-
son can present as restrictive or impulsive. Against this
background, we further suggest that it is temperamental
dominance that dictates which behaviour is more fre-
quently observed (restrictive vs. impulsive), for example,
a person with AN who is generally restrictive, but with
bouts of binging and purging. Temperamental domin-
ance might also underlie personality characteristics, e.g.
a person with a restrained eating disorder might also be
introverted and mildly psychotic, a person with an im-
pulsive eating disorder might present features of
extroversion and neuroticism. Temperamental domin-
ance, we purport, is determined by inherent neurobio-
logical factors that are acquired genetically, but modified
epigenetically via learned interactions with new environ-
mental challenges (e.g. during puberty), particularly in
those who develop eating disorders [50].
It is of note that despite its apparent appeal, body
weight may not be the most accurate measure to indi-
cate one’s position on the spectrum, because for ex-
ample, some people with bulimia are able to excessively
exercise to compensate for high levels of food consump-
tion - a factor that makes bulimia nervosa difficult to de-
tect and treat. Furthermore, cognitive and personality
traits often precede starvation and are sometimes
present following weight restoration. It could be that
questionnaire measures of temperament (e.g. Restraint
Scale [51], Eysenck Impulsivity Questionnaire [52]) will
prove more appropriate for measuring susceptibility or
current diagnosis of disordered eating behaviour at a
given timepoint. Thus, in the proposed spectrum model,
a fluctuating temperament linked to eating could present
(e.g. restraint, binge-purge, extroversion-introversion),
but it is the temperamental dominance, persisting over
time (e.g. excessive restriction, excessive food consump-
tion, regardless of compensatory measures) that deter-
mines ones true place on the model.
Another major caveat to the proposed model are the
recent findings that self-starvation may evoke reward
responses in the brain [53,54]. In line with animal models
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starvation becomes a rewarding and/or motivating factor.
However, despite fMRI studies showing increased striatal
responses in females with AN, it is to images of thin bod-
ies (which are probably rewarding for a person with AN
to look at, relative to larger bodies). Previous fMRI
studies using images of bodies (e.g. [55-57] show differ-
ent neural responses to food stimuli, and appetitive acti-
vation is the main focus of the model proposed here.
Furthermore, it could be that the striatal response to self-
starvation does not reflect reward, but rather an
increased motivational state (which could explain a
greater propensity to exercise in AN, despite energy defi-
cits), akin to the evolutionary homeostatic drive to seek
food [58]. Given that the motivation neural circuity, al-
though shown to be separate, is closely tied to reward
responses in the mesolimbic pathway (e.g. [59]), it might
be difficult to separate food seeking behaviour from
pleasurable responses to food in those with AN. The
problem of the model therein lies: how to differentiate
between striatal responses associated with seeking, and
striatal responses associated with impulsive and excessive
binge eating. In an attempt to account for this discrep-
ancy, we again emphasise temperamental dominance: a
person with AN who has excessive striatal-induced seek-
ing behaviour, provoked by prolonged restraint of appe-
tite, would still have (over time) a dominant PFC-related
restraint phenotype. We do not propose that one cannot
have striatal (or other reward-related responses) in con-
junction with top-down restraint, rather, we suggest that
it is one of the extremes of the model that will ‘win out’
to highlight the person’s temperamental dominance dur-
ing a given time period. Finally, according to the model
we propose, it is not only striatal responses that predict
impulsive eating behaviour, but also responses in the
amygdala, cerebellum and hypothalamus.
In summary, brain imaging studies support a taxonomy
for a spectrum model of ED, whereby increased PFC
responses to food stimuli correspond to reduced con-
sumption of food, cognitive restraint and rigidity, obses-
sive ruminations about food, perfectionism and high
attention to detail - symptoms that are typically observed
in people with AN. Conversely, increased mesolimbic re-
ward responses to food stimuli may correspond to
greater consumption of food, impulsivity and high
arousal, lack of control and aversive social situations (e.g.
problems in relating positively to others), promiscuity
and alcoholism – symptoms that are sometimes observed
in people with BN and also those with obesity. This pat-
tern of neural activation can easily be mapped on to the
previously presented spectrum model (see Figure 1). In
both extremes, an imbalanced convergence on the insula
may lead to a rate-limiting defect [45] that heightens the
experience of anxiety and fear, particularly for the waythe body feels (a phobia that could perhaps be termed,
pathodysmorphia). Finally, it must be noted that we sug-
gest that it is the temperamental dominance of a particu-
lar extreme (e.g. restriction versus impulsivity) that
produces phenotypic behavior, and that reduction in one
dominant extreme could present a new dominance at the
opposing extreme, if the secondary dominance is suffi-
ciently activated (e.g. a new presentation of impulsivity
that was previously suppressed by excessive restriction).
Potential genetic markers underlying disordered eating
behaviour
In the next section, we discuss contemporary genetic
findings that may help to explain how these patterns of
brain activation occur in people with ED. It must be
noted that the proposed candidate genes might in part
contribute to the etiology of ED, but their effects are
quite small and exploratory genetic studies of ED in
their infancy. Furthermore, it is most likely that complex
gene-environment interactions and epigenetic effects
play a greater part in the pathophysiology of ED [50].
Nevertheless, we introduce some exciting candidate
genes to provoke additional debate about the role of
genes in the proposed impulse control model of ED.
One of the most interesting findings in genetic studies
of ED comes from a genome wide linkage test by Grice
and colleagues in 2002 [60]. By screening 386 genomic
markers in 192 families of ED affected patients, they
were able to identify an association of a region on
chromosome 1 linked to AN. This region contains,
among others, the genes encoding the delta opioid re-
ceptor 1 (OPRD1) and serotonin receptor 1D (HTR1D).
Single nucleotide polymorphisms (SNPs) in these genes
were confirmed to be associated to AN in subsequent
association studies [61,62]. Further, the candidate gene
approach (i.e. an a priori selection of genetic variations
related to genes proposed to be involved in EDs, based
on functional specification of the gene) has produced
some potential linkage to ED pathology [63]. Studies on
the Val66Met polymorphism in BDNF, which is largely
expressed in the mesolimbic reward region of the brain,
are the most robust results in association studies on EDs
to date. Through collaboration of several eating disorder
clinics across Europe, large ED patient cohorts of about
1,000 patients were assembled for association studies
and subsequent replication studies [64-68]. The 66Met
variant leads to an amino acid exchange in the func-
tional BDNF protein, from valine to methionine at pos-
ition 66, which is denoted Val66Met. This variant is one
of few for which the functional implications are known:
66Met-BDNF localizes poorly to intracellular granula
compared to 66Val-BDNF. This negatively affects secre-
tion of BDNF. Despite the large cohorts used in these
studies, replication studies from other groups are
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ation to EDs [68-73] (Reviewed in 48). Nonetheless, the
BDNF polymorphism may be linked to patterns of meso-
limbic activation observed in neuroimaging studies, but
the link is complex and undoubtedly incorporates many
other intra- and inter-cellular, as well as environmental
interactions.
The Val158Met polymorphism in catechol-o-methyl
transferase (COMT), which was originally observed to
be associated with AN in a Transmission Disequilibrium
Test (TDT) performed on 51 Israeli family trios [74],
and later observed to also be associated to BN [75], is of
particular interest as it leads to a thermodynamically
more unstable protein, which in turn leads to a lower
rate of dopamine (DA) turnover in the synaptic cleft,
particularly in the PFC. Subsequently, a higher DA activ-
ity in COMT-regulated neurons could be a predisposing
risk factor for developing EDs. Alterations in COMT ac-
tivity due to the Val158Met polymorphism is likely to
have implications for DA signaling in the PFC, as clear-
ance of DA from the synaptic cleft has been shown to be
regulated via COMT in the PFC [76]. However, a recent
meta-analysis of the COMT polymorphism alone and its
link to AN has not shown significant results [77]. Add-
itionally, despite set-shifting being potentially the most
robust endophenotype for ED pathology [78] the COMT
polymorphism alone does not relate to set-shifting
impairments observed in AN and BN [79]. Both these
findings suggest, as we imply in our model, that it is an
interaction between genotypes (e.g. COMT vs. BDNF)Figure 3 Neurobiological impulse-control model of temperamental dthat might lead to a specific ED cognitive and appetitive
phenotypes (See Figure 3).
Variants related to agouti related protein (AGRP) have
been associated with EDs, which is a central mediator of
appetite via feeding regulating hypothalamic neuronal
circuits; and SK3, a protein which regulates ion flow
through the NMDA receptor [68,80-83]. AGRP acts as
an antagonist on the melanocortin 4 receptor and blocks
the anorexigenic effect of α-melanocyte stimulating hor-
mone (α-MSH). Melanocortin 4 receptor antagonists are
very effective in reversing different types of anorectic
conditions in animal models, for example, selective mela-
nocortin MC4 receptor blockage reduces immobilization
stress-induced anorexia in rats [84].
The monoaminergic system has long been believed to
be involved in the development of EDs. This is partly
due to the psychiatric co-morbidities such as depression
and anxiety disorders such as obsessive compulsive dis-
order which are commonly observed in patients diag-
nosed with AN. Also, clinical findings show increased
CSF monoamine metabolite concentrations detected in
AN patients [85]. Early findings of an association of a
SNP in the promoter region of the gene encoding the
5-HT receptor 2a (5HT2A) to development of AN by
Collier et al. [86], also led to this SNP being the single
most studied genetic variant in genetic research in EDs.
14 studies have to date been published on this one SNP
alone, 28 papers in total on association studies on SNPs
related to serotonin function [63]. Despite this intense
focus on variations in the gene encoding 5HT2Aominance in ED.
Brooks et al. BMC Psychiatry 2012, 12:76 Page 8 of 11
http://www.biomedcentral.com/1471-244X/12/76replication studies have been highly inconsistent in
their results [63,86]. Some promising preliminary
results have been published on various other SNPs
associated with genes related to serotonin function such
as 5HT1D [61,62], 5HT2C [87-90], the norepinephrine
transporter (NET) and monoamineoxidase A (MAOA)
[91]. However, these results have yet to be robustly
replicated in larger cohorts.
In summary, despite there being indications that cer-
tain cognitive deficits and appetitive behaviours in ED
are endophenotypic, it is not currently clear which, and
how genetic polymorphisms contribute to these beha-
viours. Neuroimaging studies in to EDs are beginning to
show consistent patterns of differential neural activation
between those with and without EDs, and between the
ED subtypes. However, it is not presently possible to
combine genetic research with neuroimaging, because
further clarification is needed about which genetic inter-
actions (not single polymorphisms) are associated with
ED pathology. Nevertheless, the proposed genes pre-
sented here are meant to provide food for thought, to
encourage debate and to prompt more clarifying genetic
research into EDs.
Summary
We are proposing that neuroimaging data of people with
eating disorders provide convincing evidence that sup-
ports a single impulse control spectrum model of eating
disorders. See Figure 3. Specifically, that reduced, or at
least dysregulation of striatal dopaminergic circuits,
combined with varying degrees of PFC-related cognitive
control contribute to the differential pathologies
observed in AN, BN and BED [24]. In addition, genetic
data suggests potential polymorphisms for EDs in the
genes encoding BDNF, COMT and 5HT2A (48), the
interactions between which may contribute to a
spectrum of disordered eating. Genetic data may
compliment neuroimaging findings, in that BDNF is
linked to synaptic plasticity in the mesolimbic reward
pathway, whereas COMT is involved in the breakdown
and clearance of dopamine arriving at the PFC. Interac-
tions between these two systems, rather than isolated
polymorphisms at each gene, may contribute to ED phe-
notypes and the neural activation observed in neuroima-
ging studies, but much more work is certainly needed.
We propose that it is the interaction between COMT-
related PFC activity and BDNF-related mesolimbic activ-
ity that contributes to an ED phenotype along a
spectrum of restrictive vs. impulsive eating behavior. An
imbalance in these systems likely leads to a dysregulated
orchestration of somatic and cognitive signals arriving at
the insular cortex, which ultimately may cause upregula-
tion of 5HT2A receptors and increased anxiety. Thus, it
is not single polymorphisms, but complex geneticinteractions (as well as gene-environment interactions
and epigenetics) that likely underpins differential neural
activation. It is plausible that increased anxiety is asso-
ciated with activation of the amygdala and with rate-
limiting defects in the insula [45]. Alterations in feeding
behaviour (e.g. applying more restraint over eating in re-
sponse to environmental factors) could lead to gene-
environment interactions and epigenetic affects that
contribute to differential functioning of these brain sys-
tems [50]. However, despite the implications of the data
reviewed here, one must bear in mind that further neu-
roimaging studies are also needed to clarify the
cognitive-emotion interactions underlying restraint vs.
impulsive behaviors, e.g. by using fMRI paradigms that
utilize cognitive tasks, and connectivity analysis. It is also
of note that with increasing knowledge of structural dif-
ferences among ED patients (e.g. using voxel-based
morphometry, VBM) it will be vital to covary for struc-
tural brain differences in future brain imaging studies.
Moreover, although genetic studies are convincing in
this context, for ED, genetic data are still in their infancy
and need further clarification. See Figure 3 for an illus-
tration of the impulse control model of ED.
Strengths and limitations of the model
Our model supports transdiagnostic spectrum theories
of eating disorders [2,3,91,92] proposing that current
diagnoses are ‘snapshots in the course of a single eating
ED’ [3] and that in reality the dimensions underlying
disordered eating are fluid and subject to bidirectional
fluctuation across ED symptoms over the course of ill-
ness. We are proposing that it is fluctuating levels of re-
straint and impulsivity that underlie the presentation of
a particular eating disorder at a given time point, and
that it is plausible to veer between restraint and impul-
sivity (although temperamental dominance determines
true phenotype over extended periods). Our model is
also in line with a recent model of obesity that proposes
a switch between top-down control to mesolimbic
responses driving impulsive eating behaviour [93]. How-
ever, our model has some difficulty in accounting for a
“mixed eating disorder” diagnosis, for those who seem to
concurrently exhibit both restrictive and binge-purge
symptoms, or who, for example, begin with anorectic
symptoms but veer into bulimia and then EDNOS. Fur-
thermore, the model incorporates the notion that
healthy people without ED symptoms (e.g. ‘normalcy’)
may exhibit, on occasion, unhealthy eating behaviors (e.
g. binge eating during social gatherings, excessive dieting
at the start of a new year), but without the behavior be-
coming pathological (e.g. on the extremes of the
spectrum). Our model also provides thresholds (e.g. level
of restrictive vs. impulsive eating behavior) to indicate
where normal ends and pathological begins as a useful
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‘extreme’, and would enable EDNOS cases to be identi-
fied on a measure of ED severity based on such thresh-
olds. Measures could adopt personality and temperament
questionnaires (e.g. Restraint Scale, Impulsivity Ques-
tionnaire) rather than weight. Another important issue is
that neuroimaging studies still often show controversial
and inconsistent results, due to methodological and ana-
lytical differences, scanning procedures and equipment,
paradigms selected s Thus, despite the excellent reviews
so far on the topic of neuroimaging in ED [21-24], it is
still premature to draw definite conclusions about the
findings of brain imaging research.
Conclusions
It seems that the proposals for the new ED criteria in
DSM-V are beginning to embrace a transdiagnostic
spectrum approach by relaxing the rigid number of
binges and purges required, removing rigid diagnostic
language (e.g. intense fear, refusal) and by extending the
impulsive extreme of the ED spectrum by including BED.
Incorporating a trans-diagnosis in the development of
DSM-V can only strengthen the likelihood that ED suf-
fers will escape EDNOS in favor of a definite diagnosis
on a disordered eating behavior spectrum that likely fluc-
tuates over a lifetime. This potential mindset shift will no
doubt be, in part, fuelled by advances in neuroscientific
research that will enable researchers to delve into and
further clarify the neurobiological underpinnings that
shape the ED mind, ready for further improvements in
the DSM-VI. With the continued advancement of neu-
roimaging and genetic technologies, it might be possible
in the future to measure at which point a person lies on
this spectrum, using a simple brain scan or blood sample.
Nevertheless, in the advent of the publication of the
DSM-V, changes to the rigid criteria and the inclusion of
a broader spectrum of EDs are a positive step in the right
direction to improve diagnosis and treatment. Here we
present an impulse control spectrum model of EDs, in
order to add to the current debate on the transdiagnostic
approach to diagnosis and treatment.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
All authors (SJB, MRA, CB, HBS) contributed to the planning and writing of
the manuscript, the concept was initially devised by SB and MRA. All authors
read and approved the final manuscript.
Acknowledgements
The authors were supported by the Swedish Research Council (K2010-64X-
08268-23-3; 2010–2696), Brain Research Foundation, Novo Nordisk, Tore
Nilsons foundation, Gunvor och Josef Anérs stiftelse, Åhlens foundation, LR
Åkerhams foundation. The funding sources had no input in the design and
conduct, interpretation or preparation of this review, or in the approval of
the manuscript.Received: 30 November 2011 Accepted: 14 May 2012
Published: 6 July 2012References
1. Fairburn CG, Bohn K: Eating disorder NOS (EDNOS): an example of the
troublesome “not otherwise specified” (NOS) category in DSM-IV. Behav
Res Ther 2005, 43(6):691–701.
2. Fairburn CG, Cooper Z, Bohn K, O’Connor ME, Doll HA, Palmer RL: The
severity and status of eating disorder NOS: implications for DSM-V.
Behav Res Ther 2007, 45(8):1705–1715.
3. Fairburn CG, Cooper Z: Eating disorders, DSM-5 and clinical reality. Br J
Psychiatry 2011, 198(1):8–10.
4. DSM-5 Development. American Psychiatric Association. http://www.dsm5.org)
(24/09/2010.
5. In Distribution of eating disorders. Edited by Hoek HW. New York: Guilford;
2002.
6. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL:
Prevalence, heritability, and prospective risk factors for anorexia nervosa.
Arch Gen Psychiatry 2006, 63(3):305–312.
7. Hildebrandt T, Bacow T, Markella M, Loeb KL: Anxiety in anorexia nervosa
and its management using family-based treatment. Eur Eat Disord Rev
2012, 20(1):e1–e16.
8. Becker AE, Eddy KT, Perloe A: Clarifying criteria for cognitive signs and
symptoms for eating disorders in DSM-V. Int J Eat Disord 2009,
42(7):611–619.
9. Bravender T, Bryant-Waugh R, Herzog D, Katzman D, Kreipe RD, Lask B, Le
Grange D, Lock J, Loeb K, Madden S, et al: Classification of child and
adolescent eating disturbances. Workgroup for Classification of Eating
Disorders in Children and Adolescents (WCEDCA). Int J Eat Disord 2007,
40(Suppl):S117–S122.
10. Attia E, Roberto CA: Should amenorrhea be a diagnostic criterion for
anorexia nervosa? Int J Eat Disord 2009, 42(7):581–589.
11. Peat C, Mitchell JE, Hoek HW, Wonderlich SA: Validity and utility of
subtyping anorexia nervosa. Int J Eat Disord 2009, 42(7):590–594.
12. Fassino S, Piero A, Gramaglia C, Daga GA, Gandione M, Rovera GG, Bartocci
G: Clinical, psychological, and personality correlates of asceticism in
anorexia nervosa: from saint anorexia to pathologic perfectionism.
Transcult Psychiatry 2006, 43(4):600–614.
13. Friederich HC, Herzog W: Cognitive-behavioral flexibility in anorexia
nervosa. Curr Top Behav Neurosci 2011, 6:111–123.
14. Fairburn C, Harrison PJ: Eating Disorders. Lancet 2003, 361:407–416.
15. Jacobi C, Hayward C, de Zwaan M, Kraemer HC, Agras WS: Coming to
terms with risk factors for eating disorders: application of risk
terminology and suggestions for a general taxonomy. Psychol Bull 2004,
130(1):19–65.
16. Wilson GT, Sysko R: Frequency of binge eating episodes in bulimia
nervosa and binge eating disorder: Diagnostic considerations. Int J Eat
Disord 2009, 42(7):603–610.
17. van Hoeken D, Veling W, Sinke S, Mitchell JE, Hoek HW: The validity and
utility of subtyping bulimia nervosa. Int J Eat Disord 2009,
42(7):595–602.
18. Wonderlich SA, Gordon KH, Mitchell JE, Crosby RD, Engel SG: The validity
and clinical utility of binge eating disorder. Int J Eat Disord 2009,
42(8):687–705.
19. Couturier J, Lock J: What is recovery in adolescent anorexia nervosa? Int J
Eat Disord 2006, 39(7):550–555.
20. Keel PK, Holm-Denoma JM, Crosby RD: Clinical significance and
distinctiveness of purging disorder and binge eating disorder. Int J Eat
Disord 2011, 44(4):311–316.
21. van Kuyck K, Gerard N, Van Laere K, Casteels C, Pieters G, Gabriels L, Nuttin
B: Towards a neurocircuitry in anorexia nervosa: evidence from
functional neuroimaging studies. J Psychiatr Res 2009, 43(14):1133–1145.
22. Kaye WH, Fudge JL, Paulus M: New insights into symptoms and
neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009,
10(8):573–584.
23. Van den Eynde F, Treasure J: Neuroimaging in eating disorders and
obesity: implications for research. Child Adolesc Psychiatr Clin N Am 2009,
18(1):95–115.
24. Kaye WH, Wagner A, Fudge JL, Paulus M: Neurocircuitry of eating
disorders. Current Topics in Behavioural. Neuroscience 2011, 6:37–57.
Brooks et al. BMC Psychiatry 2012, 12:76 Page 10 of 11
http://www.biomedcentral.com/1471-244X/12/7625. Pietrini F, Castellini G, Ricca V, Polito C, Pupi A, Faravelli C: Functional
neuroimaging in anorexia nervosa: a clinical approach. Eur Psychiatry
2011, 26(3):176–182.
26. Brooks SJ, O’Daly OG, Uher R, Friederich HC, Giampietro V, Brammer M,
Williams SC, Schioth HB, Treasure J, Campbell IC: Differential neural
responses to food images in women with bulimia versus anorexia
nervosa. PLoS One 2011, 6(7):e22259.
27. Brooks SJ, O’Daly O, Uher R, Friederich HC, Giampietro V, Brammer M,
Williams SC, Schioth HB, Treasure J, Campbell IC: Thinking about Eating
Food Activates Visual Cortex with Reduced Bilateral Cerebellar Activation
in Females with Anorexia Nervosa: An fMRI Study. PLoS One 2012,
7(3):e34000.
28. Hollmann M, Hellrung L, Pleger B, Schlogl H, Kabisch S, Stumvoll M,
Villringer A, Horstmann A: Neural correlates of the volitional regulation of
the desire for food. Int J Obes (Lond) 2011, 36(5):648–655.
29. Zanto TP, Rubens MT, Thangavel A, Gazzaley A: Causal role of the
prefrontal cortex in top-down modulation of visual processing and
working memory. Nat Neurosci 2011, 14(5):656–661.
30. Burger KS, Stice E: Relation of dietary restraint scores to activation of
reward-related brain regions in response to food intake, anticipated
intake, and food pictures. NeuroImage 2011, 55(1):233–239.
31. Brooks SJ, O’Daly OG, Uher R, Schioth HB, Treasure J, Campbell IC:
Subliminal food images compromise superior working memory
performance in women with restricting anorexia nervosa. Conscious Cogn
2012, 21(2):751–763.
32. El-Hage W, Phillips ML, Radua J, Gohier B, Zelaya FO, Collier DA, Surguladze
SA: Genetic modulation of neural response during working memory in
healthy individuals: interaction of glucocorticoid receptor and
dopaminergic genes. Mol Psychiatry 2011. Epub ahead of print.
33. Brooks SJ ODO, Uher R, Friederich HC, Giampietro V, Brammer M, Williams
SCR, Schiöth HB, Treasure J, Campbell IC: Differential neural responses to
food images in women with bulimia versus anorexia nervosa. PLoS One
2011, 6(7):e22259.
34. Bohon C, Stice E: Reward abnormalities among women with full and
subthreshold bulimia nervosa: a functional magnetic resonance imaging
study. Int J Eat Disord 2011, 44(7):585–595.
35. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM: Relation of reward
from food intake and anticipated food intake to obesity: a functional
magnetic resonance imaging study. J Abnorm Psychol 2008,
117(4):924–935.
36. Racine SE, Burt SA, Iacono WG, McGue M, Klump KL: Dietary restraint
moderates genetic risk for binge eating. J Abnorm Psychol 2011, 120
(1):119–128.
37. Van den Eynde F, Claudino AM, Mogg A, Horrell L, Stahl D, Ribeiro W, Uher
R, Campbell I, Schmidt U: Repetitive transcranial magnetic stimulation
reduces cue-induced food craving in bulimic disorders. Biol Psychiatry
2010, 67(8):793–795.
38. Craig AD: How do you feel–now? The anterior insula and human
awareness. Nat Rev Neurosci 2009, 10(1):59–70.
39. Joos AA, Saum B, van Elst LT, Perlov E, Glauche V, Hartmann A, Freyer T,
Tuscher O, Zeeck A: Amygdala hyperreactivity in restrictive anorexia
nervosa. Psychiatry Res 2011, 191(3):189–195.
40. Will MJ, Franzblau EB, Kelley AE: The amygdala is critical for
opioid-mediated binge eating of fat. Neuroreport 2004, 15(12):1857–1860.
41. Sperduti M, Delaveau P, Fossati P, Nadel J: Different brain structures
related to self- and external-agency attribution: a brief review and
meta-analysis. Brain Struct Funct 2011, 216(2):151–157.
42. Bruch H: Perceptual and conceptual disturbances in anorexia nervosa.
Psychosom Med 1962, 24:187–194.
43. Hambrook D, Oldershaw A, Rimes K, Schmidt U, Tchanturia K, Treasure J,
Richards S, Chalder T: Emotional expression, self-silencing, and distress
tolerance in anorexia nervosa and chronic fatigue syndrome. Br J Clin
Psychol 2010, 50(3):310–325.
44. Oldershaw A, Hambrook D, Tchanturia K, Treasure J, Schmidt U: Emotional
theory of mind and emotional awareness in recovered anorexia nervosa
patients. Psychosom Med 2010, 72(1):73–79.
45. Nunn K, Frampton I, Fuglset TS, Torzsok-Sonnevend M, Lask B: Anorexia
nervosa and the insula. Med Hypotheses 2011, 76(3):353–357.
46. Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A: Neuroimaging and
obesity: current knowledge and future directions. Obes Rev 2011,
13(1):43–56.47. Frankort A, Roefs A, Siep N, Roebroeck A, Havermans R, Jansen A: Reward
activity in satiated overweight women is decreased during unbiased
viewing but increased when imagining taste: an event-related fMRI
study. Int J Obes (Lond) 2011, 36(5):627–37.
48. Goldner E: Treatment refusal in anorexia nervosa. Int J Eat Disord 1989,
8(3):297–306.
49. Wonderlich SA, Lilenfeld LR, Riso LP, Engel S, Mitchell JE: Personality and
anorexia nervosa. Int J Eat Disord 2005, 37(Suppl):S68–71. discussion
S87-69.
50. Campbell IC, Mill J, Uher R, Schmidt U: Eating disorders, gene-
environment interactions and epigenetics. Neurosci Biobehav Rev 2011,
35(3):784–793.
51. Herman CP, Polivy J: Anxiety, restraint, and eating behavior. J Abnorm
Psychol 1975, 84(6):66–72.
52. Eysenck SPPEGAJ: Age norms for impulsiveness, venturesomeness and
empathy in adults. Pers Indiv Differ 1985, 6:613.
53. Fladung AK, Gron G, Grammer K, Herrnberger B, Schilly E, Grasteit S, Wolf
RC, Walter H, von Wietersheim J: A neural signature of anorexia nervosa in
the ventral striatal reward system. Am J Psychiatry 2010, 167(2):206–212.
54. Keating C, Tilbrook AJ, Rossell SL, Enticott PG, Fitzgerald PB: Reward
processing in anorexia nervosa. Neuropsychologia 2012, 50(5):567–575.
55. Vocks S, Schulte D, Busch M, Gronemeyer D, Herpertz S, Suchan B: Changes
in neuronal correlates of body image processing by means of
cognitive-behavioural body image therapy for eating disorders: a
randomized controlled fMRI study. Psychol Med 2011, 41(8):1651–1663.
56. Vocks S, Busch M, Gronemeyer D, Schulte D, Herpertz S, Suchan B: Neural
correlates of viewing photographs of one’s own body and another
woman’s body in anorexia and bulimia nervosa: an fMRI study.
J Psychiatry Neurosci 2010, 35(3):163–176.
57. Friederich HC, Brooks S, Uher R, Campbell IC, Giampietro V, Brammer M,
Williams SC, Herzog W, Treasure J: Neural correlates of body
dissatisfaction in anorexia nervosa. Neuropsychologia 2010, 48(10):2878–
2885.
58. Alcaro A, Panksepp J: The SEEKING mind: primal neuro-affective
substrates for appetitive incentive states and their pathological
dynamics in addictions and depression. Neurosci Biobehav Rev 2011,
35(9):1805–1820.
59. Smith KS, Berridge KC, Aldridge JW: Disentangling pleasure from incentive
salience and learning signals in brain reward circuitry. Proc Natl Acad Sci
U S A 2011, 108(27):E255–E264.
60. Grice DE, Halmi KA, Fichter MM, Strober M, Woodside DB, Treasure JT,
Kaplan AS, Magistretti PJ, Goldman D, Bulik CM, et al: Evidence for a
susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum
Genet 2002, 70(3):787–792.
61. Bergen AW, van den Bree MB, Yeager M, Welch R, Ganjei JK, Haque K,
Bacanu S, Berrettini WH, Grice DE, Goldman D, et al: Candidate genes for
anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta
opioid receptor loci exhibit significant association to anorexia nervosa.
Mol Psychiatry 2003, 8(4):397–406.
62. Brown KM, Bujac SR, Mann ET, Campbell DA, Stubbins MJ, Blundell JE:
Further evidence of association of OPRD1 & HTR1D polymorphisms with
susceptibility to anorexia nervosa. Biol Psychiatry 2007, 61(3):367–373.
63. Rask-Andersen M, Olszewski PK, Levine AS, Schioth HB: Molecular
mechanisms underlying anorexia nervosa: focus on human gene
association studies and systems controlling food intake. Brain Res Rev
2010, 62(2):147–164.
64. Ribases M, Gratacos M, Armengol L, de Cid R, Badia A, Jimenez L, Solano R,
Vallejo J, Fernandez F, Estivill X: Met66 in the brain-derived neurotrophic
factor (BDNF) precursor is associated with anorexia nervosa restrictive
type. Mol Psychiatry 2003, 8(8):745–751.
65. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M,
Cavallini MC, Cellini E, Di Bella D, Erzegovesi S, et al: Association of BDNF
with anorexia, bulimia and age of onset of weight loss in six European
populations. Hum Mol Genet 2004, 13(12):1205–1212.
66. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M,
Cristina Cavallini M, Cellini E, Di Bella D, Erzegovesi S, et al: Association of
BDNF with restricting anorexia nervosa and minimum body mass index:
a family-based association study of eight European populations. Eur J
Hum Genet 2005, 13(4):428–434.
67. Ribases M, Gratacos M, Badia A, Jimenez L, Solano R, Vallejo J, Fernandez-
Aranda F, Estivill X: Contribution of NTRK2 to the genetic susceptibility to
Brooks et al. BMC Psychiatry 2012, 12:76 Page 11 of 11
http://www.biomedcentral.com/1471-244X/12/76anorexia nervosa, harm avoidance and minimum body mass index. Mol
Psychiatry 2005, 10(9):851–860.
68. Dardennes RM, Zizzari P, Tolle V, Foulon C, Kipman A, Romo L, Iancu-
Gontard D, Boni C, Sinet PM, Therese Bluet M, et al: Family trios analysis
of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP
genes in patients with Anorexia nervosa: association with subtype,
body-mass index, severity and age of onset. Psychoneuroendocrinology
2007, 32(2):106–113.
69. Dmitrzak-Weglarz M, Skibinska M, Slopien A, Szczepankiewicz A, Rybakowski
F, Kramer L, Hauser J, Rajewski A: BDNF Met66 allele is associated with
anorexia nervosa in the Polish population. Psychiatr Genet 2007,
17(4):245–246.
70. Friedel S, Horro FF, Wermter AK, Geller F, Dempfle A, Reichwald K, Smidt J,
Bronner G, Konrad K, Herpertz-Dahlmann B, et al: Mutation screen of the
brain derived neurotrophic factor gene (BDNF): identification of several
genetic variants and association studies in patients with obesity, eating
disorders, and attention-deficit/hyperactivity disorder. Am J Med Genet B
Neuropsychiatr Genet 2005, 132B(1):96–99.
71. Koizumi H, Hashimoto K, Itoh K, Nakazato M, Shimizu E, Ohgake S, Koike K,
Okamura N, Matsushita S, Suzuki K, et al: Association between the
brain-derived neurotrophic factor 196 G/A polymorphism and eating
disorders. Am J Med Genet B Neuropsychiatr Genet 2004, 127B(1):125–127.
72. Rybakowski F, Dmitrzak-Weglarz M, Szczepankiewicz A, Skibinska M, Slopien
A, Rajewski A, Hauser J: Brain derived neurotrophic factor gene Val66Met
and -270 C/T polymorphisms and personality traits predisposing to
anorexia nervosa. Neuroendocrinol Lett 2007, 28(2):153–158.
73. de Krom M, Bakker SC, Hendriks J, van Elburg A, Hoogendoorn M, Verduijn
W, Sinke R, Kahn R, Adan RA: Polymorphisms in the brain-derived
neurotrophic factor gene are not associated with either anorexia
nervosa or schizophrenia in Dutch patients. Psychiatr Genet 2005, 15(2):81.
74. Frisch A, Laufer N, Danziger Y, Michaelovsky E, Leor S, Carel C, Stein D, Fenig
S, Mimouni M, Apter A, et al: Association of anorexia nervosa with the
high activity allele of the COMT gene: a family-based study in Israeli
patients. Mol Psychiatry 2001, 6(2):243–245.
75. Hinney A, Scherag S, Hebebrand J: Genetic findings in anorexia and
bulimia nervosa. Prog Mol Biol Transl Sci 2010, 94:241–270.
76. Kaenmaki M, Tammimaki A, Myohanen T, Pakarinen K, Amberg C,
Karayiorgou M, Gogos JA, Mannisto PT: Quantitative role of COMT in
dopamine clearance in the prefrontal cortex of freely moving mice.
J Neurochem 2010, 114(6):1745–1755.
77. Brandys MK, Slof-Op’t Landt MC, van Elburg AA, Ophoff R, Verduijn W,
Meulenbelt I, Middeldorp CM, Boomsma DI, van Furth EF, Slagboom E, et al:
Anorexia nervosa and the Val158Met polymorphism of the COMT gene:
meta-analysis and new data. Psychiatr Genet 2012, 22(3):130–136.
78. Holliday J, Tchanturia K, Landau S, Collier D, Treasure J: Is impaired set-
shifting an endophenotype of anorexia nervosa? Am J Psychiatry 2005,
162(12):2269–2275.
79. Kim YR, Kim JE, Kim MH: Impaired Set-Shifting Ability in Patients with
Eating Disorders, Which Is Not Moderated by Their Catechol-O-
Methyltransferase Val158Met Genotype. Psychiatry Investig 2010,
7(4):298–301.
80. Koronyo-Hamaoui M, Danziger Y, Frisch A, Stein D, Leor S, Laufer N, Carel C,
Fennig S, Minoumi M, Apter A, et al: Association between anorexia
nervosa and the hsKCa3 gene: a family-based and case control study.
Mol Psychiatry 2002, 7(1):82–85.
81. Koronyo-Hamaoui M, Gak E, Stein D, Frisch A, Danziger Y, Leor S,
Michaelovsky E, Laufer N, Carel C, Fennig S, et al: CAG repeat
polymorphism within the KCNN3 gene is a significant contributor to
susceptibility to anorexia nervosa: a case–control study of female
patients and several ethnic groups in the Israeli Jewish population. Am J
Med Genet B Neuropsychiatr Genet 2004, 131B(1):76–80.
82. Koronyo-Hamaoui M, Frisch A, Stein D, Denziger Y, Leor S, Michaelovsky E,
Laufer N, Carel C, Fennig S, Mimouni M, et al: Dual contribution of NR2B
subunit of NMDA receptor and SK3 Ca(2+)-activated K + channel to
genetic predisposition to anorexia nervosa. J Psychiatr Res 2007,
41(1–2):160–167.
83. Vink T, Hinney A, van Elburg AA, van Goozen SH, Sandkuijl LA, Sinke RJ,
Herpertz-Dahlmann BM, Hebebrand J, Remschmidt H, van Engeland H, et al:
Association between an agouti-related protein gene polymorphism and
anorexia nervosa. Mol Psychiatry 2001, 6(3):325–328.84. Vergoni AV, Bertolini A: Role of melanocortins in the central control of
feeding. Eur J Pharmacol 2000, 405(1–3):25–32.
85. Kaye WH, Ebert MH, Raleigh M, Lake R: Abnormalities in CNS monoamine
metabolism in anorexia nervosa. Arch Gen Psychiatry 1984, 41(4):350–355.
86. Collier DA, Arranz MJ, Li T, Mupita D, Brown N, Treasure J: Association
between 5-HT2A gene promoter polymorphism and anorexia nervosa.
Lancet 1997, 350(9075):9412.
87. Hu X, Giotakis O, Li T, Karwautz A, Treasure J, Collier DA: Association of the
5-HT2c gene with susceptibility and minimum body mass index in
anorexia nervosa. Neuroreport 2003, 14(6):781–783.
88. Nacmias B, Ricca V, Tedde A, Mezzani B, Rotella CM, Sorbi S: 5-HT2A
receptor gene polymorphisms in anorexia nervosa and bulimia nervosa.
Neurosci Lett 1999, 277(2):134–136.
89. Westberg L, Bah J, Rastam M, Gillberg C, Wentz E, Melke J, Hellstrand M,
Eriksson E: Association between a polymorphism of the 5-HT2C receptor
and weight loss in teenage girls. Neuropsychopharmacology 2002,
26(6):789–793.
90. Urwin RE, Bennetts BH, Wilcken B, Lampropoulos B, Beumont PJ, Russell JD,
Tanner SL, Nunn KP: Gene-gene interaction between the monoamine
oxidase A gene and solute carrier family 6 (neurotransmitter transporter,
noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype).
Eur J Hum Genet 2003, 11(12):945–950.
91. Waller G: A ‘trans-transdiagnostic’ model of the eating disorders: a new
way to open the egg? Eur Eat Disord Rev 2008, 16(3):165–172.
92. Oldershaw A, Treasure J, Hambrook D, Tchanturia K, Schmidt U: Is anorexia
nervosa a version of autism spectrum disorders? Eur Eat Disord Rev 2011,
19(6):462–474.
93. Volkow ND, Wang GJ, Fowler JS, Telang F: Overlapping neuronal circuits in
addiction and obesity: evidence of systems pathology. Philos Trans R Soc
Lond B Biol Sci 2008, 363(1507):3191–3200.
doi:10.1186/1471-244X-12-76
Cite this article as: Brooks et al.: A debate on current eating disorder
diagnoses in light of neurobiological findings: is it time for a spectrum
model?. BMC Psychiatry 2012 12:76.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
